Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.34
0.131.80%
At close: -
$7.38
0.040.54%
After Hours: 4:40 PM EDT
Comments
Loading...
Corbus Pharmaceuticals Stock Price, Quotes and Forecasts
CRBPNASDAQ
Corbus Pharmaceuticals (CRBP) Forecast
NewsEarningsCorbus Pharmaceuticals (CRBP) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Corbus Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:CRBP | Benzinga
Explore Corbus Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRBP.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Corbus Pharmaceuticals (CRBP) stock?
You can purchase shares of Corbus Pharmaceuticals (NASDAQ:CRBP) through any online brokerage.
Who are Corbus Pharmaceuticals (CRBP) competitors?
Other companies in Corbus Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), OncoCyte (NASDAQ:OCX) and Inozyme Pharma (NASDAQ:INZY).
What is the forecast, or price target, for Corbus Pharmaceuticals (CRBP) stock?
Corbus Pharmaceuticals has a consensus price target of $53.56.
What is the current price for Corbus Pharmaceuticals (CRBP)?
The stock price for Corbus Pharmaceuticals (NASDAQ: CRBP) is $7.38 last updated May 16, 2025 at 4:40 PM EDT.
Does Corbus Pharmaceuticals (CRBP) pay a dividend?
There are no upcoming dividends for Corbus Pharmaceuticals.
When is Corbus Pharmaceuticals (NASDAQ:CRBP) reporting earnings?
Corbus Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 5, 2025.
Is Corbus Pharmaceuticals (CRBP) going to split?
There is no upcoming split for Corbus Pharmaceuticals.
What sector and industry does Corbus Pharmaceuticals (CRBP) operate in?
Corbus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
